Read More Here
“The FDA estimates that PGx pharmacogenomic testing will save the healthcare industry $136+ Billion annually.”
There were 2.2 million adverse drug effects in 2016 (ADR’s, also known as “Adverse Drug Reactions”) annually cause 700,000 deaths. This has a higher cost than all cardiovascular and diabetic costs combined.” FACTS:
- Only 58% of patients receive relief from pain medications
- 30% of pain patients have a genetic opioid metabolic defect
- 50% of patients with depression do not respond to the first medication prescribed for their treatment
- 30% discontinue treatment due to intolerable ADR’s (Adverse Drug Reactions)
- 70% who receive medications for depression are non-adherent – with ADR’s being the most common reason
- 700,000 patients are treated in Emergency Rooms as a result of ADR’s
- 9.7% of ADR’s cause permanent damage to patients
- $47 Billion in annual hospitalization costs related to ADR’s
- $76.6 Billion annual cost of drug therapy morbidity or mortality
SOURCE: US Institutes of Medicine and Journal of American Medical Association